Everest Medicines (Singapore) Pte. Ltd. is a Singapore-based subsidiary of Everest Medicines, a biopharmaceutical company focused on licensing, developing, and commercializing innovative therapeutics in Asia. The company's portfolio includes products targeting oncology, infectious diseases, immunology, and other critical therapeutic areas with unmet medical needs. Its business model centers on in-licensing clinical-stage or approved drugs from global pharmaceutical partners and advancing regulatory approvals, commercialization, and distribution within Asian markets. The Singapore entity supports regional corporate, investment, and partnership functions within the group's broader Asia-focused strategy. Everest Medicines' strategic focus emphasizes accelerating access to innovative therapies, building regional regulatory and commercialization capabilities, and establishing partnerships to strengthen its pipeline of differentiated medicines.
Legal Address
36 Robinson Road, #20-01, City House, Singapore 068877
Singapore; Singapore;
Postal Code: 068877
Contact Details: Purchase the Everest Medicines (Singapore) Pte. Ltd. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service